Breast cancer cells also upregulated the expression of PD-1, TIM-3 and/or LAG-3, but not CTLA-4, in CD4+CD25+ T cells (comprising of activated T cells and Tregs). The gene discussed is HAVCR2; the disease is breast carcinoma.